Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, USA, May 11, 2026 (GLOBE NEWSWIRE) -- Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight The personalized medicine market is...
-
Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Cell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ResearchAndMarkets.com's...
-
Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Procrit Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
New York, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The hemophilia clinical...
-
Dallas, TX, May 01, 2026 (GLOBE NEWSWIRE) -- Two prominent leaders in the medical technology industry, Dr. Navid Khodaparast, Chief Science Officer and Co-Founder of Spark Biomedical, and Dr. Amy...
-
New York, USA, April 28, 2026 (GLOBE NEWSWIRE) -- Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight The AAV vector manufacturing...
-
STUDIO CITY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- As this year’s Myeloma Action Month came to a close, the International Myeloma Foundation (IMF) was truly grateful for the incredible support...
-
AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are...
-
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
-
Biovance, Biovance 3L, Natalin, Acelagraft, Interfyl and Centaflex licensed to NEXGEL are established commercial products widely used today in wound care, orthopedics and other indications.Three...